Russia's Gamaleya applies for emergency COVID-19 vaccine use in the Philippines

Russia's Gamaleya Research Institute has applied to the Philippine health regulator for emergency use authorization of its COVID-19 vaccine, the regulator said late Friday.

Gamaleya's emergency use application is the third the Philippine Food and Drug Administration has received after Pfizer and AstraZeneca both made similar applications.